Takeover in Pumps Watson–Marlow Boosts Biopharma–Business with Asepco–Takeover
Pump specialist Watson Marlow Fluid Technology buys bioprocessing technology supplier Asepco for £ 7.0 million (€ 9.6 million). This step could significantly strengthen Watson's biopharmaceutical offering.
Falmouth/United Kingdom – Watson-Marlow Fluid Technology has acquired Asepco through its parent company Spirax-Sarco Engineering, for £7.0 million. Asepco, based in California USA, specialises in the design and manufacture of high purity aseptic valves and magnetic mixers for the bioprocessing industry.
Watson–Marlow sees Asepco as a natural extension of its fluid path product portfolio, strengthening the company's global presence in the biotechnology and pharmaceutical industries. Asepco complements Watson’s range by utilising patented, market-leading technology to improve sterility levels within the biotechnology production process. This improved process sterility reduces the risks surrounding validation in demanding contamination-free applications. This generates greater levels of confidence for our customers.
Jay Whalen, President of the Watson-Marlow Fluid Technology comments: "The strategic acquisition of Asepco further broadens our product range and strengthens Watson-Marlow's position in the biopharmaceutical market. This enables us to provide a more comprehensive and improved service to our customers looking for sterility throughout their fluid path. This is another exciting milestone for Watson-Marlow and we are looking forward to accelerating our growth within the biopharmaceutical market with our broadened product portfolio coupled to our process expertise”.
Steve Joy, Asepco President will remain in his role. Steve brings a wealth of experience to WMFTG. Prior to joining Asepco, Steve had previous experience of founding and growing a business with Jensen Fittings. Joy commented, “I am very excited to be part of the Watson-Marlow Fluid Technology Group and look to drive sales further with the expansive WMFTG sales network.”